Skip directly to content


Zyvox is a synthetic antibacterial agent of a class of antibiotics – oxazolidinones, which has clinical utility in facing infections caused by some Gram-positive bacteria including resistant strains1. Zyvox inhibits bacterial protein synthesis through a mechanism of action different from that of other antibacterial agents. Zyvox has a well-tolerated side effect profile and provides both intravenous and oral formulations1.


  1. Zyvox (linezolid) Prescribing Information. Pfizer Corporation Hong Kong Limited: Version March 2018.
[PP-CPF-HKG-0063] SEP 2019